Growth Hormone & Acromegaly (FOI/193)


Message from the customer - 03 December 2020

About your request for information

Subject - what is this request about?
Request regarding prescribing in growth hormone & acromegaly

What information are you requesting?
Dear University Hospitals Coventry and Warwickshire NHS Trust,

I hope that you are well.

I have a freedom of information request that I need your help with. I understand the pressures the entire NHS is currently under, but I would greatly appreciate your assistance. Could you please answer the questions below?

1. How many patients has your trust treated in the last 12 months with the following drugs?
• Octreotide
• Lanreotide
• Pasireotide
• Pegvisomant
• Genotropin
• Humatrope
• Norditropin
• Nutropin
• Omnitrope
• Saizen
• Zomacton

2. Please provide the number of patients under the age 16 that were treated in the last 12 months with each of the following drugs:
• Genotropin
• Humatrope
• Norditropin
• Nutropin
• Omnitrope
• Saizen
• Zomacton

3. How many patients have been treated in the last 12 months with the following drugs for Acromegaly (ICD10 code E22.0) ONLY?
• Sandostatin LAR
• Octreotide Long-Acting (Generic)
• Somatuline Autogel
• Pasireotide

Thank you in advance for your assistance and I hope everybody at the trust stays safe in this challenging time.

Kind regards,
***** *****





 




Message from the customer - 04 December 2020

Hi Hardeep, who is best to deal with this FOI request around growth hormone usage and acromegaly? For a change it"s not cancer chemotherapy medicine related.
Steve

From: [email protected] [mailto:[email protected]]
Sent: 04 December 2020 08:43
To: Almond Stephen (RKB) Associate Director of Pharmacy
Subject: [FOI/193] Request Assigned - Deadline 18/12/2020















Infreemation

You are being assigned this as an individual user

You have been assigned a new information request FOI/193 by Daniel Gilbert :

Can I ask for you to please take a look at this Freedom of Information and let me have your response by 18/12/

If you think that another department should have input then please can you point me in the right direction ASAP, so that we can avoid any delays and allow enough time for the correct person to respond.

Kind regards
The deadline for this assignment has been set to 18/12/2020. Please ensure you respond before this date.

Login













You have received this email because you are a registered user of Infreemation. For more information please contact our support desk






Infreemation Website | Digital Interactive Ltd 2004-2020









DISCLAIMER: This email and any attachments are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient you must not copy this message or any attachment or disclose the contents to any other person, nor take any action in reliance of its contents: to do so is strictly prohibited and may be unlawful. If you have received this message in error please accept our apologies and contact us at the address below or by email at [email protected] Any files attached to this email will have been checked by us with virus detection software before transmission. You should carry out your own virus checks before opening any attachment. UHCW (University Hospitals Coventry and Warwickshire NHS Trust) accepts no liability for any loss or damage which may be caused by software viruses. Any views or opinions expressed are those of the author and do not represent the views of the Trust unless explicitly stated. The information contained in this email may be subject to public disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this email and your reply cannot be guaranteed. Address: UHCW NHS Trust, Executive suite, 3rd Floor Rotunda, University Hospital, Clifford Bridge Road, Coventry, CV2 2DX




Message from the customer - 21 December 2020

?
?
?
I am away from the office returning 21/12/2020 AM. If it is urgent please contact main pharmacy via switchboard.

DISCLAIMER: This email and any attachments are confidential and may be privileged or otherwise protected from disclosure. If you are not the intended recipient you must not copy this message or any attachment or disclose the contents to any other person, nor take any action in reliance of its contents: to do so is strictly prohibited and may be unlawful. If you have received this message in error please accept our apologies and contact us at the address below or by email at [email protected] Any files attached to this email will have been checked by us with virus detection software before transmission. You should carry out your own virus checks before opening any attachment. UHCW (University Hospitals Coventry and Warwickshire NHS Trust) accepts no liability for any loss or damage which may be caused by software viruses. Any views or opinions expressed are those of the author and do not represent the views of the Trust unless explicitly stated. The information contained in this email may be subject to public disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this email and your reply cannot be guaranteed. Address: UHCW NHS Trust, Executive suite, 3rd Floor Rotunda, University Hospital, Clifford Bridge Road, Coventry, CV2 2DX




Message from UHCW - 05 January 2021

Our Ref: FOI/193
Date: 5 January 2021


By email only

 

Dear Requester


We write further to your request for information under the Freedom of Information Act received 3 December 2020.  We have set out your request, together with our response below. 

1. How many patients has your trust treated in the last 12 months with the following drugs?


• Octreotide - 84
• Lanreotide - 172
• Pasireotide - 0
• Pegvisomant - 0
• Genotropin - 49
• Humatrope - 0
• Norditropin - 1-10
• Nutropin - 24
• Omnitrope - 38
• Saizen - 0
• Zomacton - 1-10


2. Please provide the number of patients under the age 16 that were treated in the last 12 months with each of the following drugs:


• Genotropin - 32
• Humatrope - 0
• Norditropin - 1-10
• Nutropin - 0
• Omnitrope - 34
• Saizen - 0
• Zomacton - 0


3. How many patients have been treated in the last 12 months with the following drugs for Acromegaly?

• Sandostatin LAR - 1-10
• Octreotide Long-Acting (Generic) - 0
• Somatuline Autogel - 19
• Pasireotide - 0

(ICD10 code E22.0) ONLY – We do not have this detail

 

Please note that due to the availability of inferred or derived information from other sources, there may be a risk of identification owing to the very low numbers involved. For this reason, we are only able to provide you with aggregated answers.